Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

Approvals/CIMA-AEMPS/ZINNAT 500 MG COMPRIMIDOS RECUBIERTOS CON PELICULA

Approved

STANDARD

ZINNAT 500 MG COMPRIMIDOS RECUBIERTOS CON PELICULA

Glaxosmithkline (Ireland) Limited🇪🇸 Spanish Agency of Medicines and Medical Devices

Approval Date: Sep 22, 2022
Approval ID: b12fe6ea27ba23ba
Company: Glaxosmithkline (Ireland) Limited
Type: Standard

Approval Details

Approval Id: b12fe6ea27ba23ba
Drug Cima Aemps Name: ZINNAT 500 MG COMPRIMIDOS RECUBIERTOS CON PELICULA
Register Number: 15-061-88-C-CIP
Holder Company Name: Glaxosmithkline (Ireland) Limited
Marketing Company Name: Elam Pharma Labs S.L.
Holder Company Detail Path: /organization/glaxosmithkline-ireland-limited
Authorization Date: 2022-09-22
Dosage Form: COMPRIMIDO RECUBIERTO CON PELÍCULA
Dose: 500 mg cefuroxima axetilo
Route Of Administration: VÍA ORAL
Prescription Type: Medicamento Sujeto A Prescripción Médica
Commercialized: No
Company Name: Glaxosmithkline (Ireland) Limited
Company Detail Path: /organization/glaxosmithkline-ireland-limited

Company Information

Pharmaceutical Company Name: GLAXOSMITHKLINE (IRELAND) LIMITED
Country Name: Ireland
City Name: dublin,country_ie
Address: 12 RIVERWALK

Active Ingredients

CEFUROXIMA AXETILO

601,44 mg

Approved

Quick Info

Agency

CIMA-AEMPS

Country

🇪🇸

Approval Date

Sep 22, 2022

Approval ID

b12fe6ea27ba23ba

Type

Standard

Back to CIMA-AEMPS Approvals

ZINNAT 500 MG COMPRIMIDOS RECUBIERTOS CON PELICULA - CIMA-AEMPS Drug Approval Details